TREATMENT CENTER

TreatmentCenter.co.uk news Dental Implant

Clinipace Selected to Present at Health Care Innovations Conference
Jul 28, 2006

Clinipace, Inc., a software company focused on late-stage clinical research studies and registries has been selected to present at the preeminent healthcare conference for leading start-up companies and skilled investors, Health Care Innovations 2006.
Source: http://www.prweb.com/releases/2006/7/prweb416911.htm

(PRWEB) July 28, 2006 -- Clinipace, Inc., a software company focused on late-stage clinical research studies and registries has been selected to present at the preeminent healthcare conference for leading start-up companies and skilled investors, Health Care Innovations 2006.
The Health Care Innovations Conference, being held September 12th and 13th in Redwood City, California, features keynote speakers from the U.S. Food and Drug Administration, Merck, Bill and Melinda Gates Foundation, and Pfizer.

Sponsored by Dow Jones and VentureWire, the conference’s program will focus on successful private companies who are committed to “Finding and Funding the Cures of Tomorrow,” and will spotlight promising opportunities in life sciences research and new information technologies.

By combining proprietary startup formation and investment data together with the domain expertise of their editors and reporters, Dow Jones/VentureWire is uniquely positioned to shed light on the most topical issues facing those who are building these companies, as well as identifying those startups which exhibit the best prospects to take leadership positions. Dow Jones/VentureWire rated several hundred startups on a host of internal criteria before inviting those companies demonstrating true business momentum.

Jeff Williams, CEO of Clinipace, states, “We are pleased to be chosen from among some of the country's most exciting private companies who will present to leading industry executives and investors in healthcare. The Health Care Innovations Conference is a well-regarded event and we believe a great venue for sharing our vision for the future of web-based clinical research and how we are positioned to deliver it.”

About Clinipace
Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Our platform, called Tempo, is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research.

For more information on Clinipace, please visit: www.clinipace.com

For more information on the Dow Jones Healthcare Innovations Conference, visit www.healthcare.dowjones.com

###


TreatmentCenter.co.uk news Dental Implant Clinipace Selected to Present at Health Care Innovations Conference Jul 28, 2006 Clinipace, Inc., a software company focused on late-stage clinical research studies and registries has been selected to present at the preeminent healthcare conference for leading start-up companies and skilled investors, Health Care Innovations 2006. Source: http://www.prweb.com/releases/2006/7/prweb416911.htm (PRWEB) July 28, 2006 -- Clinipace, Inc., a software company focused on late-stage clinical research studies and registries has been selected to present at the preeminent healthcare conference for leading start-up companies and skilled investors, Health Care Innovations 2006. The Health Care Innovations Conference, being held September 12th and 13th in Redwood City, California, features keynote speakers from the U.S. Food and Drug Administration, Merck, Bill and Melinda Gates Foundation, and Pfizer. Sponsored by Dow Jones and VentureWire, the conference’s program will focus on successful private companies who are committed to “Finding and Funding the Cures of Tomorrow,” and will spotlight promising opportunities in life sciences research and new information technologies. By combining proprietary startup formation and investment data together with the domain expertise of their editors and reporters, Dow Jones/VentureWire is uniquely positioned to shed light on the most topical issues facing those who are building these companies, as well as identifying those startups which exhibit the best prospects to take leadership positions. Dow Jones/VentureWire rated several hundred startups on a host of internal criteria before inviting those companies demonstrating true business momentum. Jeff Williams, CEO of Clinipace, states, “We are pleased to be chosen from among some of the country's most exciting private companies who will present to leading industry executives and investors in healthcare. The Health Care Innovations Conference is a well-regarded event and we believe a great venue for sharing our vision for the future of web-based clinical research and how we are positioned to deliver it.” About Clinipace Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Our platform, called Tempo, is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace, please visit: www.clinipace.com For more information on the Dow Jones Healthcare Innovations Conference, visit www.healthcare.dowjones.com ###

- Treatmnet center - Price List - Contact -